Clinical Trials
4 trialsNCT05692661 2023-01-20
A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer
Shanghai Proton and Heavy Ion Center
Phase 1 Unknown
NCT05189067 2022-01-12
Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2/3 Unknown
NCT04717531 2021-06-04
Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT03006614 2017-01-16
PERS
Sun Yat-sen University
Phase 3 Unknown